Applied DNA Sciences (NASDAQ: APDN) reported Q3 EPS of ($0.13), $0.19 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $4.3 million versus the consensus estimate of $4.14 million.

For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.